(PRESS RELEASE) CAMBRIDGE, 8-Nov-2024 — /EuropaWire/ — AstraZeneca and Amgen have announced positive Phase III trial results ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...

TEZSPIRE demonstrated a statistically significant and clinically meaningful reduction in nasal polyp size and reduced nasal congestion compared to placebo ...

The above clinic adds that this creates a self-perpetuating cycle, as the body relies on the spray to alleviate symptoms, ...

Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

Nasal sprays, especially decongestant nasal sprays (DNSs), offer quick relief by shrinking swollen blood vessels in the nasal ...

It's frustrating to deal with sinus problems, and the pollution just makes everything worse, leaving me feeling helpless and ...